Overview

A Dose Ranging Study to Evaluate Safety and Efficacy of Bromfenac Ophthalmic Solution in Dry Eye Disease

Status:
Completed
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
A dose ranging study to evaluate safety and efficacy of bromfenac ophthalmic solution in dry eye disease.
Phase:
Phase 3
Details
Lead Sponsor:
Bausch & Lomb Incorporated
Treatments:
Bromfenac
Ophthalmic Solutions
Pharmaceutical Solutions